Top

Published in:

Open Access 01-12-2022 | Sarcopenia | Research

Prevalence and associated factors of possible sarcopenia and sarcopenia: findings from a Chinese community-dwelling old adults cross-sectional study

Authors: Jiazhi Wang, Changge Liu, Lin Zhang, Ning Liu, Lei Wang, Jingqiong Wu, Yizhao Wang, Huimin Hao, Longjun Cao, Shilei Yuan, Liping Huang

Published in: BMC Geriatrics | Issue 1/2022

Abstract

Purpose

To describe the prevalence and analyse the associated factors of possible sarcopenia and sarcopenia among community-dwelling old adults in China, in order to provide effective strategies for early prevention and treatment of sarcopenia.

Methods

This cross-sectional study evaluated community-dwelling old adults aged over 60 years. The basic information, morphological indices, body composition, physical activities were collected and assessed. Possible sarcopenia and sarcopenia were diagnosed by the criteria of Asian Working Group for Sarcopenia (AWGS) in 2019. A multivariate logistic regression model with stepwise method was employed to identify factors associated with possible sarcopenia and sarcopenia.

Results

In total 729 old adults from Tianjin were included in this study. Eighty-one participants were diagnosed with possible sarcopenia (prevalence of 11.11%). Seventy-five participants were diagnosed with sarcopenia (prevalence of 10.29%). Age (odds ratio (OR):1.047, 95% confidence interval (CI): 1.055–1.090) and lower physical activities (low level OR:4.171, 95% CI:1.790–9.720; medium level OR:2.634, 95% CI:1.352–5.132) were significantly associated with possible sarcopenia. Age (OR:1.187, 95% CI:1.124–1.253), higher body fat percentage (OR:1.225, 95% CI:1.140–1.317), lower BMI (OR:0.424, 95% CI:0.346–0.519), lower mini-mental state examination (MMSE) scores (OR:0.865,95% CI:0.781–0.958) and low physical activities (OR:4.638, 95% CI:1.683–12.782) were significantly associated with sarcopenia.

Conclusion

Possible sarcopenia and sarcopenia are prevalent among community-dwelling old adults in China. Ageing and lower physical activities were both associated with possible sarcopenia and sarcopenia. Old adults with sarcopenia more likely have higher body fat percentage, lower BMI and lower cognitive function compared with those without this condition.

Tang T, Wu L, Yang L, Jiang J, Hao Q, Dong B, et al. A sarcopenia screening test predicts mortality in hospitalized older adults. Sci Rep. 2018;8(1):2923. https://doi.org/10.1038/s41598-018-21237-9.CrossRefPubMedPubMedCentral

Rondanelli M, Klersy C, Terracol G, et al. Whey protein, amino acids, and vitamin D supplementation with physical activity increases fat-free mass and strength, functionality, and quality of life and decreases inflammation in sarcopenic elderly. Am J Clin Nutr. 2016;103(3):830–40. https://doi.org/10.3945/ajcn.115.113357.CrossRefPubMed

Patel HP, Dennison EM, Westbury L, Sayer AA, Copper C. Sarcopenia and bone health in community dwelling older adults: findings from the hertfordshire sarcopenia study (HSS). Age Ageing. 2017;46(suppl 2):ii8. https://doi.org/10.1093/ageing/afx117.28.CrossRef

Bauer JM, Sieber CC. Sarcopenia and frailty: a clinician’s controversial point of view. Exp Gerontol. 2008;43(7):674–8. https://doi.org/10.1016/j.exger.2008.03.007.CrossRefPubMed

Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Lijima K, et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300–7. https://doi.org/10.1016/j.jamda.2019.12.012.CrossRefPubMed

Schaap LA, Van NS, Lips P, Visser M. Associations of sarcopenia definitions, and their components, with the incidence of recurrent falling and fractures; the Longitudinal Aging Study Amsterdam. J Gerontol A Biol Sci Med Sci. 2018;73(9):1199–204. https://doi.org/10.1093/gerona/glx245.CrossRefPubMed

Leong DP, Teo KK, Rangarajan S, Lopez-Jaramillo P, Avezum A Jr, Orlandini A, et al. Prognostic value of grip strength: findings from the prospective urban rural epidemiology (PURE) study. Lancet. 2015;386:266–73. https://doi.org/10.1016/S0140-6736(14)62000-6.CrossRefPubMed

Schaap LA, Koster A, Visser M. Adiposity, muscle mass, and muscle strength in relation to functional decline in older persons. Epidemiol Rev. 2013;35(1):51–65. https://doi.org/10.1093/epirev/mxs006.CrossRefPubMed

Carmeli E. Frailty and primary sarcopenia: a review. Adv Exp Med Biol. 2017;1020:53–68. https://doi.org/10.1007/5584_2017_18.CrossRefPubMed

10.

Wu X, Li X, Xu M, Zhang Z, He L, Li Y. Sarcopenia prevalence and associated factors among older Chinese population: findings from the China health and retirement longitudinal study. PLoS One. 2021;16(3):e0247617. https://doi.org/10.1371/journal.pone.0247617.CrossRefPubMedPubMedCentral

11.

Miura H, Sakaguchi K, Ogawa W, Tamori Y. Clinical features of 65-year-old individuals in Japan diagnosed with possible sarcopenia based on the Asian Working Group for Sarcopenia 2019 criteria. Geriatr Gerontol Int. 2021;21(8):689–96. https://doi.org/10.1111/ggi.14182.CrossRefPubMed

12.

Kim M, Won CW. Sarcopenia in Korean community-dwelling adults aged 70 years and older: application of screening and diagnostic tools from the Asian working group for sarcopenia 2019 update-science direct. J Am Med Dir Assoc. 2020;21(6):752–8. https://doi.org/10.1016/j.jamda.2020.03.018.CrossRefPubMed

13.

Murphy RA, Ip EH, Zhang Q, Boudreau RM, Cawthon PM, Newman AB, et al. Transition to sarcopenia and determinants of transitions in older adults: a population-based study. J Gerontol A Biol Sci Med Sci. 2014;69(6):751–8. https://doi.org/10.1093/gerona/glt131.CrossRefPubMed

14.

Wang T, Feng X, Zhou J, Gong H, Xia S, Wei Q, et al. Type 2 diabetes mellitus is associated with increased risks of sarcopenia and pre-sarcopenia in Chinese elderly. Sci Rep. 2016;6:38937. https://doi.org/10.1038/srep38937.CrossRefPubMedPubMedCentral

15.

Xu W, Wang M, Jiang CM, Zhang YM. Anthropometric equation for estimation of appendicular skeletal muscle mass in Chinese adults. Asia Pac J Clin Nutr. 2011;20(4):551–6 https://search.informit.org/doi/10.3316/ielapa.688409051529343.

16.

Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for clinician. J Psychiatr Res. 1975;12(3):189–98. https://doi.org/10.1016/0022-3956(75)90026-6.CrossRefPubMed

17.

Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–95. https://doi.org/10.1249/01.MSS.0000078924.61453.FB.CrossRefPubMed

18.

Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213. https://doi.org/10.1016/0165-1781(89)90047-4.CrossRefPubMed

19.

Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31. https://doi.org/10.1093/ageing/afy169.CrossRefPubMed

20.

Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on Sarcopenia in older people. Age Ageing. 2010;39(4):412–23. https://doi.org/10.1093/ageing/afq034.CrossRefPubMedPubMedCentral

21.

Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, et al. Sarcopenia in Asia: consensus report of the Asian working group for Sarcopenia. JAMDA. 2014;15(2):95–101. https://doi.org/10.1016/j.jamda.2013.11.025.CrossRefPubMed

22.

Tianjin Bureau of Statistics. Tianjin 2020 seventh national census main data bulletin. Available at: http://stats.tj.gov.cn/tjsj_52032/tjgb/202105/t20210521_5457330.html. Accessed 21 May 2021.

23.

Carmeli E, Coleman R, Reznick AZ. The biochemistry of aging muscle. Exp Gerontol. 2002;37(4):477–89. https://doi.org/10.1016/s0531-5565(01)00220-0.CrossRefPubMed

24.

Dodds RM, Syddall HE, Cooper R, Benzeval M, Deary IJ, Dennison EM, et al. Grip strength across the life course: normative data from twelve British studies. PLoS One. 2014;9(12):e113637. https://doi.org/10.1371/journal.pone.0113637.CrossRefPubMedPubMedCentral

25.

Fling BW, Knight CA, Kamen G. Relationships between motor unit size and recruitment threshold in older adults: implications for size principle. Exp Brain Res. 2009;197(2):125–33. https://doi.org/10.1007/s00221-009-1898-y.CrossRefPubMed

26.

Lexell J, Downham DY. The occurrence of fibre-type grouping in healthy human muscle: a quantitative study of cross-sections of whole vastus lateralis from men between 15 and 83 years. Acta Neuropathol. 1991;81(4):377–81. https://doi.org/10.1007/BF00293457.CrossRefPubMed

27.

Purves-Smith FM, Sgarioto N, Hepple RT. Fiber typing in aging muscle. Exerc Sport Sci Rev. 2014;42(2):45–52. https://doi.org/10.1249/JES.0000000000000012.CrossRefPubMed

28.

D’Antona G, Pellegrino MA, Adami R, Rossi R, Carlizzi CN, Canepari M, et al. The effect of ageing and immobilization on structure and function of human skeletal muscle fibres. J Physiol. 2003;552(Pt 2):499–511. https://doi.org/10.1113/jphysiol.2003.046276.CrossRefPubMedPubMedCentral

29.

Dodds R, Kuh D, Sayer AA, Cooper R. Physical activity levels across adult life and grip strength in early old age: updating findings from a British birth cohort. Age Ageing. 2013;42(6):794–8. https://doi.org/10.1093/ageing/aft124.CrossRefPubMedPubMedCentral

30.

Shen X, Wang R, Bai J. Research progress in physical activity, physical fitness and health promotion. Chin J Sports Med. 2012;31(6):363–72. https://doi.org/10.3969/j.issn.1000-6710.2012.04.016.CrossRef

31.

Wang Y, Guo X, Yan Y, Xie M, Zhang Y, Su H, et al. Research progress in pathogenesis and physical therapy of age-related sarcopenia. Chin J Sports Med. 2016;35(6):568–72,87. https://doi.org/10.16038/j.1000-6710.2016.06.010.CrossRef

32.

Zhang Y, Tan Y, Huang X, Zhang Z, Bai J, Zhang M, et al. Prevalence and risk factors of sarcopenia among the elderly in Shanghai community. Geriatr Heal Care. 2018;24(6):608–13. https://doi.org/10.3969/j.issn.1008-8296.2018.06.014.CrossRef

33.

Bowen TS, Schuler G, Adams V. Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training. J Cachexia Sarcopenia Muscle. 2015;6(3):197–207. https://doi.org/10.1002/jcsm.12043.CrossRefPubMedPubMedCentral

34.

Pedersen BK, Febbraio MA. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol. 2012;8(8):457–65. https://doi.org/10.1038/nrendo.2012.49.CrossRefPubMed

35.

Henningsen J, Pedersen BK, Kratchmarova I. Quantitative analysis of the secretion of the MCP family of chemokines by muscle cells. Mol Bio Syst. 2011;7(2):311–21. https://doi.org/10.1039/c0mb00209g.CrossRef

36.

Henningsen J, Rigbolt KT, Blagoev B, Pedersen BK, Kratchmarova I. Dynamics of the skeletal muscle secretome during myoblast differentiation. Mol Cell Proteomics. 2010;9(11):2482–96. https://doi.org/10.1074/mcp.M110.002113.CrossRefPubMedPubMedCentral

37.

Benatti FB, Pedersen BK. Exercise as an anti-inflammatory therapy for rheumatic diseases—myokine regulation. Nat Rev Rheumatol. 2015;11(2):86–97. https://doi.org/10.1038/nrrheum.2014.193.CrossRefPubMed

38.

Scisciola L, Fontanella RA, Surina, Cataldo V, Paolisso G, Barbieri M. Sarcopenia and cognitive function: role of myokines in muscle brain cross-talk. Life. 2021;11(2):173–84. https://doi.org/10.3390/life11020173.CrossRefPubMedPubMedCentral

39.

Agudelo LZ, Femenía T, Orhan F, Porsmyr-Palmertz M, Goiny M, Martinez-Redondo V, et al. Skeletal muscle PGC-1α1 modulates kynurenine metabolism and mediates resilience to stress-induced depression. Cell. 2014;159(1):33–45. https://doi.org/10.1016/j.cell.2014.07.051.CrossRefPubMed

40.

Kim M, Won CW. Sarcopenia is associated with cognitive impairment mainly due to slow gait speed: results from the Korean Frailty and Aging Cohort Study (KFACS). Int J Environ Res Public Health. 2019;16(9):1491–508. https://doi.org/10.3390/ijerph16091491.CrossRefPubMedCentral

41.

Landi F, Liperoti R, Fusco D, Mastropaolo S, Quattrociocchi D, Proia A, et al. Prevalence and risk factors of sarcopenia among nursing home older residents. J Gerontol A Biol Sci Med Sci. 2012;67(1):48–55. https://doi.org/10.1093/gerona/glr035.CrossRefPubMed

42.

Auyeung TW, Lee JSW, Leung J, Kwok T, Leung PC, Woo J. Survival in older men may benefit from being slightly overweight and centrally obese-- a 5-year follow-up study in 4,000 older adults using DXA. J Gerontol A Biol Sci Med Sci. 2010;65(1):99–104. https://doi.org/10.1093/gerona/glp099.CrossRefPubMed

43.

Cesari M, Kritchevsky SB, Baumgartner RN, Atkinson HH, Penninx BW, Lenchik L, et al. Sarcopenia, obesity, and inflammation--results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study. Am J Clin Nutr. 2005;82(2):428–34. https://doi.org/10.1093/ajcn.82.2.428.CrossRefPubMed

44.

Manini TM, Clark BC, Nalls MA, Goodpaster BH, Ploutz-Snyder LL, Harris TB. Reduced physical activity increases intermuscular adipose tissue in healthy young adults. Am J Clin Nutr. 2007;85(2):377–84. https://doi.org/10.1093/ajcn/85.2.377.CrossRefPubMed

45.

Delmonico MJ, Harris TB, Visser M, Park SW, Conroy MB, Velasquez-Mieyer P, et al. Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am J Clin Nutr. 2009;90(6):1579–85. https://doi.org/10.3945/ajcn.2009.28047.CrossRefPubMedPubMedCentral

46.

Jensen GL. Inflammation: roles in aging and sarcopenia. JPEN J Parenter Enteral Nutr. 2008;32(6):656–9. https://doi.org/10.1177/0148607108324585.CrossRefPubMed

47.

Farup J, Madaro L, Puri PL, Mikkelsen UR. Interactions between muscle stem cells, mesenchymal-derived cells and immune cells in muscle homeostasis, regeneration and disease. Cell Death Dis. 2015;6(7):e1830. https://doi.org/10.1038/cddis.2015.198.CrossRefPubMedPubMedCentral

48.

Li S, Huang LP, Wang L, Chen Y, Li L, Zhang L, et al. Effects of 12 weeks aerobic exercise combined with high speed strength training on old adults with osteosarcopenic obesity syndrome. Chin J Rehabil Med. 2020;35(4):420–6. https://doi.org/10.3969/j.issn.1001-1242.2020.04.007.CrossRef

49.

Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):146–56. https://doi.org/10.1093/gerona/56.3.m146.CrossRef

50.

Gao Q, Hu K, Yan C, Zhao B, Mei F, Chen F, et al. Associated factors of sarcopenia in community-dwelling older adults: a systematic review and meta-analysis. Nutrients. 2021;13(12):4291. https://doi.org/10.3390/nu13124291.CrossRefPubMedPubMedCentral

51.

Martinez BP, Batista AKMS, Gomes IB, Olivieri FM, Camelier FWRC, Camelier AA. Frequency of sarcopenia and associated factors among hospitalized elderly patients. BMC Musculoskelet Disord. 2015;16:108. https://doi.org/10.1186/s12891-015-0570-x.CrossRefPubMedPubMedCentral

Title: Prevalence and associated factors of possible sarcopenia and sarcopenia: findings from a Chinese community-dwelling old adults cross-sectional study
Authors: Jiazhi Wang
Changge Liu
Lin Zhang
Ning Liu
Lei Wang
Jingqiong Wu
Yizhao Wang
Huimin Hao
Longjun Cao
Shilei Yuan
Liping Huang
Publication date: 01-12-2022
Publisher: BioMed Central
Keyword: Sarcopenia
Published in: BMC Geriatrics / Issue 1/2022
Electronic ISSN: 1471-2318
DOI: https://doi.org/10.1186/s12877-022-03286-y

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2022

How accurate are geriatricians’ fall predictions?

Fostering the implementation of transitional care innovations for older persons: prioritizing the influencing key factors using a modified Delphi technique

Feasibility, acceptability, and preliminary effectiveness of the adapted Namaste Care program delivered by caregivers of community-dwelling older persons with moderate to advanced dementia: a mixed methods feasibility study

Can the WHO ‘s recommendations of physical activity volume decrease the risk of heart disease in middle and older aged Chinese People: the evidence from a seven year longitudinal survey

Higher hemoglobin levels are associated with better physical performance among older adults without anemia: a longitudinal analysis

Plasma repressor element 1-silencing transcription factor levels are decreased in patients with Alzheimer's disease

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials